Pfizer (NYSE: PFE) director James Quincey granted 1,595 phantom units
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Quincey James reported acquisition or exercise transactions in this Form 4 filing.
Pfizer director James Quincey received a grant of 1,595.307 Phantom Stock Units linked to Pfizer common stock. The units were valued at $24.29 each and increase his deferred Phantom Stock Unit balance to 87,993.957 units following the transaction.
Each unit represents one phantom share of common stock and forms part of deferred director compensation, including dividend equivalents. These amounts are to be settled in cash or common stock, at the director's election, after he retires from Pfizer’s Board of Directors.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Quincey James
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Phantom Stock Units | 1,595.307 | $24.29 | $39K |
Holdings After Transaction:
Phantom Stock Units — 87,993.957 shares (Direct, null)
Footnotes (1)
- Each unit represents one phantom share of common stock. These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.
Key Figures
Phantom Stock Units granted: 1,595.307 units
Unit reference value: $24.29 per unit
Total Phantom Stock Units after grant: 87,993.957 units
+1 more
4 metrics
Phantom Stock Units granted
1,595.307 units
Grant of Phantom Stock Units on June 26, 2026
Unit reference value
$24.29 per unit
Recorded value per Phantom Stock Unit for this grant
Total Phantom Stock Units after grant
87,993.957 units
Director’s Phantom Stock Unit balance following transaction
Underlying common stock link
1 unit = 1 share
Each unit represents one phantom share of common stock
Key Terms
Phantom Stock Units, deferred director's compensation, dividend equivalents, settled in cash or common stock
4 terms
Phantom Stock Units financial
"Each unit represents one phantom share of common stock."
Phantom stock units are company promises that pay a cash or stock-equivalent award tied to the firm’s share price or value growth, but they do not issue actual shares. Think of them as a bonus check that moves with the stock like a mirror rather than handing over an ownership slice. Investors care because these awards can affect a company’s future cash obligations, executive incentives and reported expenses without causing share dilution.
deferred director's compensation financial
"These units represent deferred director's compensation (including dividend equivalents thereon)..."
dividend equivalents financial
"These units represent deferred director's compensation (including dividend equivalents thereon)..."
Payments tied to employee or contractor equity awards that mirror the cash dividends paid on the company’s stock; they give the holder the same economic benefit as owning the shares without transferring actual shares—often paid in cash or additional award units when the award becomes payable. Investors care because these payments affect a company’s compensation costs, cash flow and potential share dilution, and they signal how management is being rewarded and aligned with shareholders.
settled in cash or common stock financial
"…that are settled in cash or common stock at the director's election…"
FAQ
What insider transaction did Pfizer (PFE) report for James Quincey?
Pfizer reported that director James Quincey received 1,595.307 Phantom Stock Units as deferred compensation. Each unit tracks one share of Pfizer common stock and is part of his long-term director compensation program.
What are Phantom Stock Units in the Pfizer (PFE) Form 4 filing?
Phantom Stock Units are bookkeeping units, each representing one phantom share of Pfizer common stock. They reflect deferred director compensation and dividend equivalents, and are settled later in cash or common stock rather than through immediate stock issuance.
At what value were James Quincey’s Pfizer Phantom Stock Units recorded?
The 1,595.307 Phantom Stock Units granted to James Quincey were recorded at $24.29 per unit. This establishes the reference value for this deferred compensation award tied to Pfizer’s common stock performance.
How many Pfizer Phantom Stock Units does James Quincey hold after this transaction?
After this grant, James Quincey holds a total of 87,993.957 Phantom Stock Units. This balance represents accumulated deferred director compensation, including dividend equivalents, to be settled after he retires from the Pfizer Board.
When will James Quincey’s Pfizer Phantom Stock Units be settled?
The Phantom Stock Units will be settled after James Quincey retires from Pfizer’s Board of Directors. At that time, he may elect to receive settlement in either cash or Pfizer common stock, according to the plan’s terms.
Does the Pfizer (PFE) Form 4 show a stock purchase or sale by James Quincey?
The Form 4 does not show an open-market stock purchase or sale by James Quincey. It reports a grant of Phantom Stock Units as deferred director compensation, a routine, non-market transaction settled in the future.